Asenar
.
///
Borsa
Biz
YZGÜCÜ
BİST
HS Ekranı
Takip
Portföy
BES
Kazan
Haber
Araçlar
Premium
⌂
☀️
Biz
YZGÜCÜ
BİST
HS Ekranı
Takip
Portföy
BES
Kazan
Haber
Araçlar
Premium
Sabitler
Temettüler
Blog
Ekip
Giriş
Çıkış
BIST Hub
›
Biotechnology
› ANGEN
Research
BIST: ANGEN
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
BIST Main
Halal
İstanbul
🔔
Set Alert
⚖
Compare
Share
11.17 TRY
Source:
KAP
Market Cap
TRY
2,457,400,000 TRY
USD
$54,406,979
EUR
—
1 USD = 45.17 TRY
Current Snapshot
- 2026 Q1
P/E Ratio
N/A
↑ vs prior period
P/B Ratio
1.41x
↓ vs prior period
Gross Margin
44.77%
Op. Margin
-28.61%
↓ vs prior period
Net Margin
-28.61%
↓ vs prior period
ROE
-2.98%
↓ vs prior period
ROA
-2.00%
Source:
KAP
Debt / Equity
0.49x
↑ vs prior period
Current Ratio
2.31x
Liquidity check
Equity Ratio
67.20%
Asset coverage
EV / EBIT
N/A
↑ vs prior period
Op. profit proxy
EV / Sales
3.51x
↑ vs prior period
Enterprise value
Piotroski F
0/9
Weak (0/9)
Altman Z-Score
2.88
↓ vs prior period
Grey Zone ⚠
Sector Benchmarks
KGK — Tümü · 11,069 companies · FY2023 (latest available)
Sector ROE
22.0%
Net Margin
10.0%
Current Ratio
1.17x
Debt/Equity
0.73x
Earnings
— Q1 2026
Net Income YoY
(vs Q1 2025)
▲ +50.6%
-52M TRY vs -105M TRY
Revenue YoY
(vs Q1 2025)
▲ +31.7%
182M TRY vs 138M TRY
Net Income QoQ
(vs Q4 2025)
▼ -123.3%
-52M TRY vs -23M TRY
Revenue QoQ
(vs Q4 2025)
▼ -75.4%
182M TRY vs 740M TRY
Latest KAP Filings
Loading filings...
🔒
Unlock Full Analysis
AI-powered analysis, historical charts and full financial data for all 729 BIST companies.
AI Analysis — strengths, risks & outlook
Financial Charts — revenue, margins, returns, valuation
Historical Comparison — full quarterly data table
Get Premium Access
Sign in to your account →
Have a legacy key?
Activate
AI Analysis
Financial Charts
Revenue vs Net Income (1M TRY)
Equity vs Liabilities (1M TRY)
Profit Margins (%)
Returns — ROE vs ROA (%)
Valuation — P/E vs P/B
Advanced Analytics
Profit Cascade (1M TRY)
Revenue & Net Income Growth % (vs prior period)
3-Layer Margin Analysis — Gross, Operating, Net (%)
DuPont ROE Decomposition
Debt Structure — Current Liabilities + Long-term Debt (1M TRY)
Get DCF Valuation
PREMIUM
Historical Comparison
Period
Revenue (1M TRY)
Net Income
Net Margin
ROE
ROA
D/E
P/E
P/B
2022 Q4
268,817,404
183,944,607
68.43%
22.53%
21.47%
0.05x
13.36x
3.01x
2023 Q4
238,205,645
71,121,066
29.86%
5.86%
4.94%
0.19x
34.55x
2.03x
2024 Q3
183,087,505
-94,434,493
-51.58%
-6.34%
-5.62%
0.13x
N/A
1.65x
2024 Q4
529,831,707
62,971,448
11.89%
4.06%
3.52%
0.15x
39.02x
1.58x
2025 Q1
138,144,781
-105,327,317
-76.24%
-6.53%
-5.55%
0.18x
N/A
1.52x
2025 Q2
159,272,524
-90,351,249
-76.24%
-6.53%
-5.55%
0.18x
N/A
1.52x
2025 Q3
509,016,261
8,568,572
-66.08%
-12.31%
-10.18%
0.21x
N/A
1.50x
2025 Q4
739,628,622
-23,302,776
-56.73%
-5.51%
-4.55%
0.21x
N/A
1.50x
2026 Q1
181,872,896
-52,038,982
1.68%
0.51%
0.40%
0.28x
215.09x
1.46x